SCHEMBL16795314

SCHEMBL16795314

Cc1nc2ccccc2nc1Oc1ccccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.54
▸ HTT P42858 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ HPGD P15428 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ MAPT P10636 3/20 0.44
▸ SLC2A1 P11166 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ PDE2A O00408 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18795929 0.84 MAPT (0.50) ALDH1A1HTTL3MBTL1TSHRKDM4E
SCHEMBL18796358 0.84 ALDH1A1 (0.56) ALDH1A1HTTL3MBTL1KDM4EHPGD
SCHEMBL24287258 0.81 ALDH1A1 (0.50) ALDH1A1L3MBTL1TSHRKDM4EHPGD
SCHEMBL18796096 0.81 KDM4E (0.44) ALDH1A1HTTL3MBTL1TSHRKDM4E
SCHEMBL18796088 0.79 L3MBTL1 (0.47) ALDH1A1L3MBTL1TSHRKDM4EHPGD
SCHEMBL18796404 0.79 LCK (0.52) ALDH1A1L3MBTL1TSHRKDM4EHPGD
SCHEMBL24287256 0.76 L3MBTL1 (0.45) ALDH1A1L3MBTL1TSHRKDM4EHPGD
SCHEMBL22372364 0.75 L3MBTL1 (0.47) ALDH1A1L3MBTL1TSHRKDM4EHPGD
SCHEMBL18292683 0.73 HRH4 (0.46) ALDH1A1L3MBTL1TSHRKDM4EHPGD
SCHEMBL804981 0.72 TSHR (0.61) ALDH1A1L3MBTL1TSHRKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108349897-B Trisubstituted silylphenoxyheterocycles and analogs 拜耳作物科学股份公司 2022-03-04 — — CN claimed
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 — — EP claimed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 — — US claimed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 — — EP claimed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 — — WO claimed
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 — — EP disclosed
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-06-16 — — US disclosed
EP-3080085-B1 FUSED BICYCLIC HETEROAROMATIC DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB BIOPHARMA SPRL (BE) 2019-08-14 — — EP disclosed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 — — US disclosed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 — — EP disclosed
US-9815797-B2 Fused bicyclic heteroaromatic derivatives as modulators of TNF activity UCB BIOPHARMA SPRL (BE) 2017-11-14 — — US disclosed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 — — WO disclosed
US-20160304470-A1 Fused Bicyclic Heteroaromatic Derivatives As Modulators of TNF Activity EVOTEC AG (DE) 2016-10-20 — — US disclosed
EP-3080085-A1 FUSED BICYCLIC HETEROAROMATIC DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB Biopharma SPRL (BE) 2016-10-19 — — EP disclosed
CN-105814022-A Fused bicyclic heteroaromatic derivatives as modulators of tnf activity UCB生物制药私人有限公司 2016-07-27 — — CN disclosed
WO-2015086523-A1 FUSED BICYCLIC HETEROAROMATIC DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB BIOPHARMA SPRL (BE) 2015-06-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304470-A1 Fused Bicyclic Heteroaromatic Derivatives As Modulators of TNF Activity TNF, TNFRSF1A, TNFRSF9 ALDH1A1 2494/4885HTT 184/4885L3MBTL1 1862/4885
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues PIK3C3, ERG28, DDT ALDH1A1 3139/4885HTT 3740/4885L3MBTL1 2453/4885
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES PIK3C3, ERG28, DDT ALDH1A1 3139/4885HTT 3740/4885L3MBTL1 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback